Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

US9840493B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9840493-B2
Application numberUS-201415028005-A
CountryUS
Kind codeB2
Filing dateOct 10, 2014
Priority dateOct 11, 2013
Publication dateDec 12, 2017
Grant dateDec 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are modified amino acids comprising a tetrazine groups according to Formula I: polypeptides, antibodies, payloads and conjugates comprising these modified amino acid residues derived from the modified amino acids, and methods of producing the polypeptides, antibodies, payloads and conjugates comprising the modified amino acid residues. The polypeptides, antibodies, payloads and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound according to formula I: or a salt thereof, wherein: Ar is V is a single bond, lower alkylene, or —W 1 —W 2 —; one of W 1 and W 2 is absent or lower alkylene, and the other is —NH—, —O—, or —S—; X 1 is —NH—, —O—, or —S—; one of Z 1 , Z 2 , and Z 3 is —N— and the others of Z 1 , Z 2 , and Z 3 are each independently —CH—; and R is lower alkyl. 2. The compound of claim 1 , wherein V is a single bond, —NH—, or —CH 2 NH—. 3. The compound of claim 1 , wherein: V is a single bond, —NH—, or —CH 2 NH—; and Ar is 4. The compound of claim 1 , wherein: V is a single bond, —NH—, or —CH 2 NH—; and Ar is 5. The compound of claim 1 , wherein: V is a single bond, —NH—, or —CH 2 NH—; and Ar is 6. The compound of claim 1 according to formula Ia: 7. The compound of claim 1 according to formula IV, V, VI or VII: or a salt thereof, wherein V is a single bond, —NH—, or —CH 2 NH—. 8. The compound of claim 1 according to formula VIII or IX: or a salt thereof, wherein V is a single bond, —NH—, or —CH 2 NH—. 9. The compound of claim 1 according to any one of formulas 2, 3, and 6-10: or a salt thereof.

Assignees

Inventors

Classifications

  • the antibody targeting a receptor, a cell surface antigen or a cell surface determinant · CPC title

  • the antibody targeting an enzyme · CPC title

  • against enzymes · CPC title

  • C07D401/12Primary

    linked by a chain containing hetero atoms as chain links · CPC title

  • having a known sequence of two or more amino acids, e.g. glutathione · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9840493B2 cover?
Provided herein are modified amino acids comprising a tetrazine groups according to Formula I: polypeptides, antibodies, payloads and conjugates comprising these modified amino acid residues derived from the modified amino acids, and methods of producing the polypeptides, antibodies, payloads and conjugates comprising the modified amino acid residues. The polypeptides, antibodies, payloads and …
Who is the assignee on this patent?
Sutro Biopharma Inc
What technology area does this patent fall under?
Primary CPC classification C07D401/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).